In Vitro Diagnostic s Market

In vitro diagnostics are tests that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.

In Vitro Diagnostic (IVD) tests are a subset of medical devices. In vitro diagnostic tests are used for in vitro examination of specimens derived from the human body to provide information for screening, diagnosis, or treatment monitoring purposes.

In Vitro Diagnostic s Market contains market size and forecasts of In Vitro Diagnostic (IVD) Products in global, including the following market information:

Global In Vitro Diagnostic (IVD) Products Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global In Vitro Diagnostic (IVD) Products Market Sales, 2017-2022, 2023-2028, (M Units)

Global top five In Vitro Diagnostic (IVD) Products companies in 2021 (%)

The global In Vitro Diagnostic (IVD) Products market was valued at 83410 million in 2021 and is projected to reach US$ 128060 million by 2028, at a CAGR of 6.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Immuno Diagnostics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of In Vitro Diagnostic (IVD) Products include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, Biomerieux, Ortho Clinical Diagnostics and Becton Dickinson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the In Vitro Diagnostic (IVD) Products manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global In Vitro Diagnostic (IVD) Products Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global In Vitro Diagnostic (IVD) Products Market Segment Percentages, by Type, 2021 (%)

Immuno Diagnostics

Chemistry Diagnostics

Molecular Diagnostics

POCT

Others

Global In Vitro Diagnostic (IVD) Products Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global In Vitro Diagnostic (IVD) Products Market Segment Percentages, by Application, 2021 (%)

Hospitals

Laboratory

Others

Global In Vitro Diagnostic (IVD) Products Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global In Vitro Diagnostic (IVD) Products Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies In Vitro Diagnostic (IVD) Products revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies In Vitro Diagnostic (IVD) Products revenues share in global market, 2021 (%)

Key companies In Vitro Diagnostic (IVD) Products sales in global market, 2017-2022 (Estimated), (M Units)

Key companies In Vitro Diagnostic (IVD) Products sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

Abbott

Danaher

Siemens Healthineers

Thermo Fisher Scientific

Sysmex

Biomerieux

Ortho Clinical Diagnostics

Becton Dickinson

Bio-Rad Laboratories

Hologic

Johnson and Johnson

Qiagen

Myriad Genetics

Wondfo

KHB

DAAN Gene

Leadman Biochemistry

Mindray

BioSino